MX2022003090A - Vacuna combinada para ser administrable intradermicamente. - Google Patents
Vacuna combinada para ser administrable intradermicamente.Info
- Publication number
- MX2022003090A MX2022003090A MX2022003090A MX2022003090A MX2022003090A MX 2022003090 A MX2022003090 A MX 2022003090A MX 2022003090 A MX2022003090 A MX 2022003090A MX 2022003090 A MX2022003090 A MX 2022003090A MX 2022003090 A MX2022003090 A MX 2022003090A
- Authority
- MX
- Mexico
- Prior art keywords
- mhyo
- pcv2
- relates
- vaccine
- administrable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19196890 | 2019-09-12 | ||
| PCT/EP2020/075454 WO2021048338A1 (en) | 2019-09-12 | 2020-09-11 | Combination vaccine for intradermal administration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2022003090A true MX2022003090A (es) | 2022-04-11 |
Family
ID=68136125
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022003090A MX2022003090A (es) | 2019-09-12 | 2020-09-11 | Vacuna combinada para ser administrable intradermicamente. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220323567A1 (https=) |
| EP (1) | EP4028050A1 (https=) |
| JP (2) | JP2022548001A (https=) |
| KR (1) | KR20220062345A (https=) |
| CN (1) | CN114364398B (https=) |
| BR (1) | BR112022004256A2 (https=) |
| CA (1) | CA3149027A1 (https=) |
| MX (1) | MX2022003090A (https=) |
| WO (1) | WO2021048338A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023118553A1 (en) | 2021-12-24 | 2023-06-29 | Intervet International B.V. | Stable emulsions of antigens |
| CN121219005A (zh) | 2023-05-12 | 2025-12-26 | 英特维特国际股份有限公司 | 一种针对猪红斑丹毒丝菌、猪细小病毒及钩端螺旋体菌的联合疫苗 |
| WO2024235714A1 (en) | 2023-05-12 | 2024-11-21 | Intervet International B.V. | A vaccine against leptospira bacterium |
| WO2024235713A1 (en) | 2023-05-12 | 2024-11-21 | Intervet International B.V. | A vaccine against erysipelothrix rhusiopathiae and porcine parvo virus |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101347503B1 (ko) | 2005-09-09 | 2014-01-02 | 인터벳 인터내셔널 비.브이. | Ｐｃｖ-2 백신 |
| MX338626B (es) | 2005-12-29 | 2016-04-26 | Boehringer Ingelheim Vetmed | Uso de una composicion inmunogenica de pcv2 para producir los sintomas clinicos en cerdos. |
| JP5200223B2 (ja) | 2006-12-15 | 2013-06-05 | ベーリンガー インゲルハイム フェトメディカ インコーポレイテッド | Ｐｃｖ２抗原によるブタの処置 |
| JP6648138B2 (ja) * | 2014-12-11 | 2020-02-14 | インターベット インターナショナル ベー． フェー． | 即時使用型ＰＣＶ２／Ｍ．ハイオ（Ｍ．ｈｙｏ）混合ワクチンのための工程 |
| CN108697782A (zh) * | 2016-03-23 | 2018-10-23 | 英特维特国际股份有限公司 | 针对pcv2病毒和猪肺炎支原体感染的组合疫苗 |
| EP3558351B1 (en) * | 2016-12-23 | 2022-01-26 | Intervet International B.V. | Combination vaccine for swine |
| US11744883B2 (en) * | 2017-12-22 | 2023-09-05 | Hipra Scientific, S.L.U. | Intradermal combination vaccine against mycoplasma and porcine circovirus |
-
2020
- 2020-09-11 US US17/641,031 patent/US20220323567A1/en active Pending
- 2020-09-11 JP JP2022515948A patent/JP2022548001A/ja active Pending
- 2020-09-11 MX MX2022003090A patent/MX2022003090A/es unknown
- 2020-09-11 CN CN202080064095.7A patent/CN114364398B/zh active Active
- 2020-09-11 CA CA3149027A patent/CA3149027A1/en active Pending
- 2020-09-11 WO PCT/EP2020/075454 patent/WO2021048338A1/en not_active Ceased
- 2020-09-11 BR BR112022004256A patent/BR112022004256A2/pt unknown
- 2020-09-11 EP EP20775220.5A patent/EP4028050A1/en active Pending
- 2020-09-11 KR KR1020227011595A patent/KR20220062345A/ko active Pending
-
2025
- 2025-03-26 JP JP2025051601A patent/JP2025106086A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4028050A1 (en) | 2022-07-20 |
| CN114364398B (zh) | 2025-08-22 |
| KR20220062345A (ko) | 2022-05-16 |
| JP2022548001A (ja) | 2022-11-16 |
| BR112022004256A2 (pt) | 2022-06-21 |
| CA3149027A1 (en) | 2021-03-18 |
| JP2025106086A (ja) | 2025-07-11 |
| CN114364398A (zh) | 2022-04-15 |
| US20220323567A1 (en) | 2022-10-13 |
| WO2021048338A1 (en) | 2021-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022003090A (es) | Vacuna combinada para ser administrable intradermicamente. | |
| RU2434638C2 (ru) | Вакцина альфа токсоида с.perfringens | |
| PH12021550479A1 (en) | Dengue vaccine unit dose and administration thereof | |
| MX388128B (es) | Vacuna combinada para cerdos. | |
| MX2010005014A (es) | Vacuna viva avirulenta de mycoplasma hyopneumoniae con adyuvante. | |
| MX2010007815A (es) | Composiciones inmunogenicas de mycoplasma hyopneumoniae contra pcv2 y metodos para producir composiciones de este tipo. | |
| BR112018069100A2 (pt) | uma vacina combinada contra a infecção por vírus pcv2 e mycoplasma hyopneumoniae | |
| GT200200138A (es) | Vacunacion en dosis unica con mycoplasma hyopneumoniae | |
| CO6150191A2 (es) | Vacuna de influenza | |
| AR108829A1 (es) | Vacuna contra virus de bronquitis infecciosa | |
| CL2008003845A1 (es) | Vacuna que comprende una emulsion, una bacterina tratada termicamente a 55-70°c por 5-10 horas, que comprende una suspension de bacterias muertas de la especie leptospira bratislava, y de 1 a 13 virus causantes de enfermedad porcina. | |
| MX2020006662A (es) | Vacuna combinada intradermica contra mycoplasma y circovirus porcino. | |
| JP2019509300A5 (https=) | ||
| JP2022548001A5 (https=) | ||
| RU2018127403A (ru) | Поливалентная вакцина против hyo и ее применение | |
| BR112016012435A8 (pt) | vacina, e, usos de uma proteína orf2 recombinantemente expressada do circovírus porcino tipo 2 | |
| BR112014023283A8 (pt) | Composição imunogênica, segunda composição imunogênica, e, método para prevenção e/ou tratamento contra doença influenza | |
| BR112022019207A2 (pt) | Composições de vacina para coronavírus e métodos de uso das mesmas | |
| BRPI0608310A2 (pt) | uso de um poxvìrus modificado para a indução rápida de imunidade contra um poxvìrus ou outros agentes infecciosos | |
| MX390682B (es) | Vacunas que contienen patogenos de cerdo para uso no mixto asociado. | |
| BR112023002804A2 (pt) | Vacinas para covid-19 com adjuvantes em emulsão de esqualeno contendo tocoferol | |
| MX2023009192A (es) | Vacuna para mycoplasma bovis. | |
| MX2022000525A (es) | Vacunas contra la ehrlichia y composiciones inmunogenicas. | |
| DK1387693T3 (da) | Saponininaktiveret mykoplasmavaccine | |
| RU2018137033A (ru) | Вакцина для внутрикожного применения против инфекции вируса pcv2 и prrs |